As part of your product development process, it’s important to determine if you need a clinical trial in order to get the product on the market.
In this course, we discuss when to start thinking about clinical trials and how to determine the right clinical trial for your product.
At the end of the course, complete the course quiz for your records.
This playbook is written in collaboration with Boulder Clinical Science, a clinical research organization that specializes in clinical trial protocol design and implementation.
Yes! There is no cost to join the Enzyme Community, but we'll soon be rolling out a number of premium features, available to Enzyme eQMS users or to those with subscriptions to the Enzyme Community.
Enzyme's eQMS content is reserved for eQMS subscribers. If you're interested in learning more or need to upgrade your account, please contact us.
Enzyme's Community offers educational content designed to teach you the ropes of regulatory compliance, quality management, and Enzyme's own eQMS, as well as opportunities for professional certification.
The Enzyme Community also offers specialized content for members like job postings, supplier intelligence data, and access to support documents and forums.
Enzyme offers certification opportunities for those looking to level up their career and professional marketability. Contact the Enzyme team to find out how to get started on your certification.
Clinical trials are a complicated weave of science, clinical medicine, logistics, contract negotiation/business, and most importantly ethics. Many companies underestimate the difficulty and cost associated with implementing a clinical trial successfully.
A clinical research trial is just that; research with a null hypothesis. The outcome is not certain, and the first clinical trial is essentially a big “bet” that your device will be safe and/or efficacious. Sometimes, the gamble may be so large that in fact, if the trial fails, likely so does your product and/or company.
Medical Device clinical trials are expensive and can range from at least 1 million USD to greater than 10 million USD each. Hence it is important to start planning early so that the adequate funds can be raised to support the trial(s). Planning early allows your company to devise a strategy that can reduce both trial cost and time. In turn, this can reduce your time to market. Depending on your designation (Class II/501(k) or class III/PMA), the FDA (or your government’s notified body) will want to see varying levels of evidence that your device is safe and effective.
Furthermore, your investors and board will want to know that you have an internal clinical team, or Clinical Research Organization (CRO), or both, to design and implement the clinical strategy and trails. Investors will shy away from inexperience, equivocal/poor trial results, or a device that has a difficult reimbursement path. Any potential future acquisition deals will benefit from higher pricing for a device that has proven value to the payers. Once on the market, the payers (Medicare/Medicaid and/or private insurance companies) will need clinical evidence of value to support reimbursement.
If your regulatory and/or strategic path includes the need for clinical data, there are ways that an experienced CRO can help your company mitigate the risk, and go into the trial with the best possible design.
Chat with other Enzyme power-users, experts, and more.
Industry news and insights from the Enzyme team and guest collaborators.
Inquire about leveling up your Enzyme experience with professional instruction.